• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本市售的10种商用诊断试剂盒中不同基因型乙型肝炎病毒表面抗原的反应性。

Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.

作者信息

Mizuochi Toshiaki, Okada Yoshiaki, Umemori Kiyoko, Mizusawa Saeko, Sato Shinichiro, Yamaguchi Kazunari

机构信息

Department of Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.

出版信息

Jpn J Infect Dis. 2005 Apr;58(2):83-7.

PMID:15858285
Abstract

Hepatitis B virus (HBV) surface antigen (HBsAg) is one of the most important serological markers of current HBV infection. However, there are significant antigenic variations of HBsAg caused by genotypic diversity as well as mutation of the HBV genome. It is predictable that amino acid substitutions occurring in the HBsAg "a" determinant of a particular HBV genotype will affect the sensitivity of some diagnostic kits, since all the diagnostic kits currently available utilize monoclonal and/or polyclonal antibodies against the "a" determinant. One possible concern is that there may be a significant variation in the sensitivity of HBsAg diagnostic kits to HBsAg encoded by HBV of different genotypes, which might result in a failure to detect HBsAg of a particular HBV genotype. In this study, we assessed the reactivity of HBsAg specimens derived from three different HBV genotypes (A, B, and C) that are prevalent in Japan by 10 commercially available EIA (enzyme immunoassay), CLIA (chemiluminescent immunoassay), and CLEIA (chemiluminescent enzyme immunoassay) diagnostic kits. Specimens included both clinical samples and recombinant HBsAg. Our results showed that all the diagnostic kits evaluated were able to detect HBsAg irrespective of HBV genotypes. At the same time, it is apparent that some, but not all of the kits showed clear differences in sensitivity to the three HBV genotypes.

摘要

乙肝病毒(HBV)表面抗原(HBsAg)是当前HBV感染最重要的血清学标志物之一。然而,由于基因型多样性以及HBV基因组的突变,HBsAg存在显著的抗原变异。可以预见,特定HBV基因型的HBsAg“a”决定簇中发生的氨基酸替换会影响某些诊断试剂盒的灵敏度,因为目前所有可用的诊断试剂盒都使用针对“a”决定簇的单克隆和/或多克隆抗体。一个可能令人担忧的问题是,HBsAg诊断试剂盒对不同基因型HBV编码的HBsAg的灵敏度可能存在显著差异,这可能导致无法检测到特定HBV基因型的HBsAg。在本研究中,我们通过10种市售的酶免疫分析(EIA)、化学发光免疫分析(CLIA)和化学发光酶免疫分析(CLEIA)诊断试剂盒,评估了源自日本流行的三种不同HBV基因型(A、B和C)的HBsAg标本的反应性。标本包括临床样本和重组HBsAg。我们的结果表明,所有评估的诊断试剂盒都能够检测HBsAg,而与HBV基因型无关。同时,很明显,部分(但不是全部)试剂盒对三种HBV基因型的灵敏度存在明显差异。

相似文献

1
Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.日本市售的10种商用诊断试剂盒中不同基因型乙型肝炎病毒表面抗原的反应性。
Jpn J Infect Dis. 2005 Apr;58(2):83-7.
2
Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.评估10种用于体外表达A至H基因型乙肝病毒(HBV)编码的乙肝病毒表面抗原的商业诊断试剂盒。
J Virol Methods. 2006 Sep;136(1-2):254-6. doi: 10.1016/j.jviromet.2006.03.022. Epub 2006 May 16.
3
A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.一种新型乙肝病毒表面抗原免疫测定法在检测早期感染时与乙肝病毒核酸检测一样灵敏。
Transfusion. 2009 Mar;49(3):585-95. doi: 10.1111/j.1537-2995.2008.02026.x. Epub 2008 Dec 12.
4
Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.乙型肝炎病毒S基因的遗传变异性:临床及诊断意义
J Clin Virol. 2005 Feb;32(2):102-12. doi: 10.1016/j.jcv.2004.10.008.
5
The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.六种乙型肝炎表面抗原检测方法的分析灵敏度和突变体检测能力。
Am J Clin Pathol. 2006 May;125(5):748-51. doi: 10.1309/K5EM-795V-NGGF-GBXX.
6
Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.通过四种商业化乙肝表面抗原(HBsAg)检测方法评估野生型和突变型乙肝表面抗原的敏感性
Clin Lab. 2004;50(3-4):159-62.
7
Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.在拜耳ADVIA Centaur免疫分析系统上进行乙肝检测的性能
Clin Lab. 2004;50(1-2):63-73.
8
An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).用于检测乙型肝炎病毒表面抗原 (HBsAg) 的 Abbott ARCHITECT 改良检测法。
J Clin Virol. 2011 May;51(1):59-63. doi: 10.1016/j.jcv.2011.01.019. Epub 2011 Mar 1.
9
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.免疫功能低下的 HBsAg 决定簇突变患者:HBsAg 诊断检测方法的比较。
Intervirology. 2010;53(3):183-7. doi: 10.1159/000289342. Epub 2010 Mar 3.
10
European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.欧洲协作评估 Enzygnost HBsAg 6.0 检测:对乙型肝炎病毒表面抗原变异体的性能。
J Med Virol. 2011 Jan;83(1):95-100. doi: 10.1002/jmv.21943.

引用本文的文献

1
Comparison of Autolumo A2000 Plus and Architect i2000 for detection of hepatitis B virus serological markers.Autolumo A2000 Plus与Architect i2000检测乙型肝炎病毒血清学标志物的比较
Heliyon. 2024 Jun 8;10(14):e32698. doi: 10.1016/j.heliyon.2024.e32698. eCollection 2024 Jul 30.
2
Reducing the risk of hepatitis B virus transfusion-transmitted infection.降低输血传播的乙型肝炎病毒感染风险。
J Blood Med. 2011;2:91-102. doi: 10.2147/JBM.S12899. Epub 2011 Jul 18.
3
Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.
台湾地区应用酶联免疫吸附试验进行乙型肝炎病毒基因分型。
Hepatol Int. 2010 Aug 3;4(3):601-7. doi: 10.1007/s12072-010-9198-y.
4
Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.全球 70 种乙型肝炎病毒 (HBV) 表面抗原 (HBsAg) 检测试剂的性能评估,该试剂来自世界各地,涵盖了多种 HBV 基因型和 HBsAg 亚型,由具有地域多样性的专家组进行评估。
Vox Sang. 2010 Apr;98(3 Pt 2):403-14. doi: 10.1111/j.1423-0410.2009.01272.x. Epub 2009 Nov 3.
5
A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.墨西哥一项系统评价显示,低水平的 HBsAg 血清流行率与乙型肝炎病毒(HBV)相关肝硬化和肝细胞癌的低发病率相关。
Hepatol Int. 2009 Jun;3(2):343-55. doi: 10.1007/s12072-008-9115-9. Epub 2008 Dec 19.